NRIX – nurix therapeutics, inc. - common stock (US:NASDAQ)
Stock Stats
News
Nurix Therapeutics: Why This Company Could Double In Value? [Seeking Alpha]
Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader-Based Medicines in Cancer and Autoimmune Diseases [Yahoo! Finance]
Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader-Based Medicines in Cancer and Autoimmune Diseases
Nurix Therapeutics (NASDAQ:NRIX) was given a new $36.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Nurix Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Form 8-K Nurix Therapeutics, Inc. For: Jan 12
Form 4 Nurix Therapeutics, Inc. For: Dec 18 Filed by: Ring Christine
Form 144 Nurix Therapeutics, Inc. Filed by: Ring Christine
Form 8-K Nurix Therapeutics, Inc. For: Dec 06
Form 4 Nurix Therapeutics, Inc. For: Nov 24 Filed by: Ring Christine
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.